“Tazret Gel 005” is not a complete procurement specification: verify that the offer is tazarotene gel 0.05% w/w, then confirm its legal status, formulation, packaging and batch documentation. By the end, you can compare suppliers on regulatory readiness, quality evidence, landed cost and destination-market suitability rather than relying on a brand name or low unit price.
Key takeaways
- Confirm Tazret Gel 005 contains tazarotene 0.05% w/w.
- Request batch-specific certificates, manufacturing records, and stability data.
- Check registration, import licences, and labeling rules in the destination market.
- Compare landed cost per usable tube, not the quoted unit price.
Verify what the supplier is actually offering
A quotation matches the requested finished medicine only when it identifies Tazret Gel 005 as tazarotene gel 0.05% w/w, equal to 0.5 mg of tazarotene per gram. “005” alone is not a sufficient regulatory description, and “tazarotene gel” could indicate another strength, a cosmetic preparation, or an unregistered compounded product.
Ask the tazret gel 005 pharmaceutical supplier to state exactly what is being sold:
- Named Tazret brand, equivalent generic, or private-label product
- Manufacturer, manufacturing site, Indian licence and GMP status
- Prescription finished medicine, cosmetic, or compounded preparation
- Net fill, such as 15 g or 30 g, tube or pump format, and primary and secondary packaging
- Full composition, gel base, excipients, preservative system, appearance and storage temperature
- Batch number, shelf life, destination-market registration or marketing authorisation
- Legal authority to supply the named brand or generic for export
Compare those answers with the purchase specification, not just the product name. Request a current pack photograph showing the active ingredient, strength, dosage form, manufacturer, batch details and prescription marking. A professional tazret gel supplier should also confirm assay, identity, impurities, microbial limits, viscosity, homogeneity and tube-seal integrity in its quality documentation.
If the quotation omits the manufacturer, strength, prescription status or batch evidence, pause the order; export availability from India does not prove that the product is authorised for sale in your country.
Request the quality dossier behind every batch
A batch is suitable for pharmaceutical supply only when its records connect the approved product specification to the physical stock offered. Ask a tazarotene gel supplier for the manufacturing site, GMP evidence, product licence, exact composition, tazarotene strength, tube or pump format, net fill, storage condition and approved shelf life.
| Document | What to verify | Failure it exposes |
|---|---|---|
| Manufacturing and specification file | Formula, excipients, preservative system, appearance, pH, viscosity or rheology, homogeneity, microbial limits, net content and tube-seal requirements | A generic “tazarotene gel” that is not the requested 0.05% finished medicine |
| Stability report | Long-term and accelerated data for the marketed pack, with storage temperature, test intervals, assay, degradation products, appearance, viscosity and microbial results | An expiry date unsupported by data for the actual tube or pump |
| Batch certificate of analysis | Batch number, manufacture and expiry dates, tazarotene identity and assay, impurities or degradation products, microbial quality and other specification limits; methods must trace to the approved specification | A certificate copied from another batch or missing critical gel tests |
| Batch-release record | Qualified-person or quality-unit approval, deviation and out-of-specification review, reconciliation, and release status | Stock held by a distributor but never formally released |
| Packaging and artwork file | Primary-pack material, seal integrity, leaflet, storage wording, prescription status and approved artwork | Labels that cannot support import, registration or sale |
Match every document to the offered batch number. Confirm whether the offer is Tazret, an equivalent generic or private label, then obtain trademark authorization or product-registration evidence where that choice requires it.
Compare tazarotene with other topical options before substituting
Do not substitute on ingredient class alone: tazarotene 0.05% w/w, equal to 0.5 mg per gram, is a prescription retinoid with distinct warnings, indications and registration requirements. A Tazret Gel wholesale quotation must identify the named brand, equivalent generic or private-label product; authorization and dossier obligations differ.
| Option | Treatment distinction | Procurement distinction |
|---|---|---|
| Tazarotene 0.05% gel | Prescription retinoid for acne and plaque psoriasis; irritation, peeling, burning and sun sensitivity require controlled use. Contraindicated during pregnancy. | Confirm exact strength, gel base, preservative system, tube or pump, storage conditions and market registration. |
| Tretinoin | Another retinoid, used mainly for acne; strength, vehicle and approved indications vary by product. | Do not treat tretinoin as an interchangeable substitute. Request its exact concentration, dosage form and local prescription status. |
| Azelaic acid | Non-retinoid option for acne and rosacea, supplied in different strengths and cream or gel vehicles. | It needs a separate product licence, label and stability file; its excipients and directions do not establish equivalence to tazarotene. |
| Salicylic acid | Keratolytic used in acne and hyperkeratotic conditions, with products ranging from regulated medicines to market-dependent over-the-counter preparations. | Compare concentration, intended use and regulatory category rather than price per tube. |
Select tazarotene when the prescriber, tender or destination registration specifically calls for it. Reject supplier copy that presents it as an unrestricted cosmetic or suitable for routine pregnancy use. The active ingredient, vehicle, pack and approved indication must match the treatment and the importing market.
Check destination-market rules before placing an export order
Do not place an export order until the destination authority confirms that Tazret Gel 0.05% may legally enter and be sold. Export availability from India does not replace local registration, import licensing or post-market safety duties.
1. Confirm the product pathway. Ask whether the country accepts the branded Indian product, requires local marketing authorisation, requires an in-country marketing-authorisation holder, or permits only a registered generic equivalent. Verify the manufacturing site’s Indian licence, GMP status, Certificate of Pharmaceutical Product and legal authority to supply the named brand.
2. Confirm prescription status and import permits. Tazarotene is often prescription-only, but the target country controls classification. Identify the importer of record, wholesale licence, controlled-document requirements and any shipment-specific permit before payment.
3. Match the approved label to the shipment. Check the local language, active ingredient and 0.05% strength, tube size, indications, age limits, directions, contraindications, pregnancy warnings, storage statement, batch number, expiry date and manufacturer details. An Indian indication cannot automatically become the legal indication abroad.
4. Define safety responsibilities in writing. A tazret gel distributor may handle stock and logistics, while the manufacturer or marketing-authorisation holder controls adverse-event reporting, medical inquiries, recalls and safety updates. Put reporting timelines and contact names in the supply agreement.
5. Request stability evidence for the destination climate. Check real-time and accelerated data, approved shelf life, storage range and transport excursions for the final tube or pump pack. Do not accept a generic stability statement that omits the marketed formulation or container.
A listing that omits registration evidence, prescription classification or batch and stability documents is not export-ready, regardless of whether it calls itself a tazret gel distributor.
Compare supplier quotes on usable, landed value
A low unit price is not the lowest procurement cost if the quote covers smaller tubes, short remaining shelf life, or an expensive import route.
Compare each offer against the same specification: 0.05% w/w tazarotene, tube or pump format, net fill, gel composition, primary and secondary packaging, batch size, storage conditions, minimum order quantity and delivery term.
| Supplier type | What to verify | Risk if unclear |
|---|---|---|
| Indian manufacturer | Manufacturing site, GMP evidence, product licence, batch release, stability data and change-control ownership | You may receive a compliant-looking product without complete release or registration support |
| Tazret gel distributor | Stock location, batch numbers, remaining shelf life, handling conditions and authority to sell the named brand | The distributor may not control formulation, recalls or pharmacovigilance |
| Generic or private-label tazarotene gel supplier | Product name, manufacturer, marketing-authorisation holder, composition and trademark position | A brand keyword may conceal an unregistered generic or a cosmetic product |
For a tazret gel wholesale quote, calculate landed cost per tube, per gram of gel and per 0.5 mg of tazarotene, then add freight, insurance, duties, inspection, document legalization and local registration work. Compare usable shelf life at arrival, not the shelf life printed at manufacture.
Put responsibilities in the contract: who supplies the Certificate of Analysis, handles temperature or humidity excursions, reports adverse events, approves changes and manages recalls. A tazret gel distributor may handle logistics while the manufacturer or marketing-authorisation holder retains quality obligations. NIBA HEALTHCARE can be assessed on the same evidence rather than on price alone.
A tazarotene gel supplier that will not identify the product, manufacturer or batch documents is not a comparable quote.
Related product
![]() | TAZAROTENE GEL 0.05 TAZRET 0.05/ GEL(TOPICAL) contains Tazarotene which belongs to the group of medicines called Retinoids. View product → |
Frequently asked questions
What should a supplier quote identify for Tazret Gel 005?
The quote should identify Tazret Gel 005 as tazarotene gel 0.05% w/w, equal to 0.5 mg per gram, and state pack size, batch details, shelf life, and manufacturer.
Which quality documents should you request for each batch?
Request the batch certificate of analysis, product specification, manufacturing and expiry dates, batch number, packaging details, and supporting quality or stability records.
Can you substitute another topical medicine for tazarotene gel?
Compare the active ingredient, strength, formulation, approved indication, irritation profile, pregnancy warnings, and destination-market status before substituting.
What export rules must you check before ordering Tazret Gel 005?
Confirm the destination product registration, importer or wholesaler licence, prescription classification, labeling language, required warnings, customs documents, and any import permit.
How should pharmaceutical supplier quotes be compared?
Compare the delivered cost per usable tube after freight, insurance, duties, taxes, bank charges, minimum order quantity, losses from short shelf life, and required testing.
